chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pfizer-BioNTech COVID- 19 Vaccine EUA: Vaccine recipient  received 2nd Pfizer dose and asked for medical assistance in the observation area. Heart rate was 100 then up to 120. No medical intervention by onsite EMS. The patient did request an ambulance and was transported to the hospital. She presented to the ED with a panic attack/anxiety. Patient was discharged to home.
2 weeks after vaccination, significant redness with mild swelling developed, without pain or itching, lasting for 2-3 days before spontaneously resolving
This spontaneous report was received from a pharmacist refers to a 57 year old female patient with latex allergy. No medical history or drug reactions were reported. On 28-OCT-2013, the patient was vaccinated with a dose of ZOSTAVAX (lot #, expiry not reported). Concomitant medication included SPORANOX. On 29-OCT-2013, the patient arm was arm was swollen, sore and warm to touch after receiving ZOSTAVAX. The patient stated she had a swollen area about the size of a golf ball at the injection site. No treatment was given. Patient sought medical attention-contacted physician. No laboratory tests were performed. The outcome of swollen area about the size of a golf ball at the injection site, arm was swollen, sore and warm to touch was reported as recovering. Additional information has been requested.
Covid positive after full vaccination, PCR positive 5/29/21 and completed vaccine series (Pfizer) 2/23/21.  Veteran hospitalized for back pain/HA.  COVID PCR positive with fever, nausea, shortness of breath, cough were symptoms of COVID.  Back pain is chronic long standing problem requiring opioid therapy and changes noted
Extreme cramps, tingling in feet + hands, cold sweats, clammy, spots in vision, nearly fainted
Welt started to develop at injection site.  Grew to size of baseball then today (09/10/2015) spread down to patients elbow.
Almost immediately these symptoms appeared:  Extremely achy joints, swollen index finger on right hand, feet and hands hurt, facial filler in right side of chin dissolved completely.  Approximately two weeks after vaccine feet and lower legs have pins and needles feel with nerves tingling.  This is a 24 hour a day problem and quite concerning.  My joints pop and creak like they suddenly  aged and have no lubrication.  These are all NEW symptoms/issues.  I?m concerned that this is a long term and/or permanent medical issue for me!  I WOULD LIKE SOME ANSWERS!!!!!
24hr p/vax t101.4-101.6, joint stiffness, soreness, h/a, chest tightness, tiredness, drowsy, poor appetite; no rash; 30SEP91 @230PM no chest tightness but other sx present; mom PC to clinic; rx: Advil; suggested mom ask about trying DPH;
Site erythema, warmth. Pt. reports nausea, malaise, fever of 102, and myalgias.
Swelling and redness of upper arm, pain in upper arm into shoulder, headache, slight fever.
After administration pt's left arm was sore. The next morning the pt could not fully extend left arm. It's 2 mos later pt cannot fully extend arm.
Within 10-15 mins after receiving my vaccination, I started to feel lightheaded and dizzy. I had numbness in my fingers, toes, face and mouth. I wasn't able to speak or move for about 4-5 mins. After about 1-2 minutes, I started to have severe chest pain on left side which was the same side as the vaccine. This chest pain lasted about 1.5 weeks. Each incident would last between 5-20 mins at a time. Numbness on face and mouth has continued. About two days later, I decided to go to urgent care. They told me I was having an anxiety attack and sent me home.
achiness; low grade fever  (97.3°F to 99.4°F); headaches; tiredness; This is a spontaneous report from a contactable consumer (patient). A 65-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number and Expiration Date: not reported) via an unspecified route of administration on 29Mar2021 as dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced achiness, low grade fever (97.3°F to 99.4°F), headaches and tiredness. The patient mentioned she would be having a dinner with some kids and was seeking information on whether she should be around kids or to just cancel. Outcome of all events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
The patient experienced a syncopal event the day following her booster. She has not experienced any episodes before.
Chills, very sore L arm to point of uselessness, night sweat, tears, sore/painful eyes, listlessness, sound sensitivity.
Information has been received from a physician concerning a patient who was vaccinated with an oral dose of Rotateq. Subsequently the patient experienced severe diarrhea and was hospitalized overnight. It was noted that that patient had been in for follow-up with the pediatrician. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Additional information has been requested.
Pt exp chills, t99.8, BP 120/80, P80; c/o shaking, h/a;
6MAR97 mom started giving APAP p/vax;pt put to be 9PM w/sl fever @ 11:00;vomited, t105 given tepid bath;called MD & put in cool bath 20min & ordered APAP & Ibuprofen alternating, t102 resting 9AM-t100.2 3PM grumpy today & sleeping >usual
Patient experienced low grade fever, erythema, bone pain for 36 hours and fatigue for 84 hours after vaccination.
Patient came in on 11/05/21 stating his right hand was numb in the middle of it on the palm. He said it was also tingling. It was just in the hand and no where else. I asked him if he spoke with his doctor and he said he called them. His doctor told him to use warm compress on it. I told him he should go in for office visit.
feeling tired, fatigued w/some dizziness & more than usual amount of effort to breath p/day 14 dose in post exposure series;had 2 doses @ hosp;had chronic eczema;felt bad;
The patient and her mother approached the pharmacy about receiving the COVID-19 vaccine and at the time of administration the only vaccine we had in stock was Moderna. The patient filled out the informed consent for the COVID-19 vaccination and was given the vaccine. It was not until after the vaccination was given that it was realized the patient was not in the age range to receive that particular vaccine
At about 30 minutes, thought I was "OK to go home" so I self-administered 25mg of benadryl (am allergic to hand sanitizer & medical facilities really bother me) and hydrOXYzine hydrochloride 25 mg - which I take as needed, (currently at 2x a day).  We scheduled my 2nd dose appointment and a few minutes after that (approx 45 min after dose) was BAM suddenly  unable to breathe. Airways clamped shut. I could feel my head hurt like it does when you can't breathe. My sister said my face was turning bright red. Nurse administered epinephrine, called for the code blue team, oxygen administered. I also had my tremors (looks like a seizure but isn't clinically a seizure) that I can also have at non-allergic episodes. Coughing / choking because I couldn't breathe, ER administered IV Benadryl &  Solu Medrol. Was able to breathe and stabilize and be discharged with a prescription for prednisone. At home I saw the purpura on my face, especially around my eyes and I continued to decide to take 25mg of Benadryl for the following 3 days. My neck, arms felt itchy though I did not see visible signs of urticaria. My lips had that "feels sunburnt" feeling that I get from other allergic reactions.
Two severe seizures 23 hours after injection, fever of 101.4. First seizures in more than a year.  Oral thrush two days after injection, fever blisters on lips three days after injection.
No additional AE occurred.; the patient only received half a dose; needle separating from the syringe during administration; needle separating from the syringe during administration; This spontaneous report was received from a registered medical assistant and refers to a 10-year-old patient of unknown gender. There was no information regarding their medical history, current conditions nor concomitant therapies provided.  On 28-APR-2021, the patient was vaccinated with a half a dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) 0.5 ml, lot # 1687290, expiration date 06-SEP-2022 (route of administration and anatomical location were not reported) for prophylaxis. The patient received only half a dose due to the needle separating from the syringe during the administration. No adverse event (AE) occurred.
This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Booster dose of Moderna COVID-19 Vaccine instead to 1st dose of Pfizer Vaccine to a 17-year-old patient) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 067H21A) for COVID-19 vaccination. No Medical History information was reported. On 05-Jan-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jan-2022, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Booster dose of Moderna COVID-19 Vaccine instead to 1st dose of Pfizer Vaccine to a 17-year-old patient). On 05-Jan-2022, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Booster dose of Moderna COVID-19 Vaccine instead to 1st dose of Pfizer Vaccine to a 17-year-old patient) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant information was not provided. Vaccine expiration date was 4/3/2022. As far as the HCP knows, the patient had not experienced any symptoms, so no treatment was given.
hearing loss; ear fullness; Her ear drum is deflated and red; This is a spontaneous report from a non-contactable consumer (parent). A 13-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not provided), via an unspecified route of administration in left arm on 25Jun2021 at 14:00 (at the age of 13-years-old) at dose number unknown, single for COVID-19 immunization. Medical and past drug history were reported as none. She was a healthy girl. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient's concomitant medications were not reported. She did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Facility where the most recent COVID-19 vaccine was administered was at a pharmacy/drug store. On 26Jun2021 at 09:00, the patient experienced ear fullness and hearing loss. There were no fever, pain, and infection. Her ear drum was deflated and red. The doctor was not sure what happened. They were not sure if it was going to go away. It has been 5 days and she has been having a hard time hearing. The events required doctor or other healthcare professional office/clinic visit. The outcome of the events was not recovered. Since the vaccination, the patient has not been tested for COVID-19.  No follow-up attempts are needed; information on lot/batch number cannot be obtained.
3/27/2023 with stiffness in the left arm and was unable to lift it up.  The next day, both arms were stiff and unable to lift up.  Participant treated this with a warm compress.  At time of reporting there is still stiffness and pain, but arm can be raised some. Both arms can?t be raised to shoulder level.
Pain and irritation at injection site immediately. Large swollen red area proximate to injection site within 24 hours.
Fever around 101F, swelling and pain on back neck, and after three days rush on all skin face, neck and head. Also muscle and joint pain. Today 11/30 /2010 still with symptoms.
3 days after receiving ZOSTAVAX patient developed a blister about 10 inches away from vaccination location.
Pfizer-BioNTech Covid-19 Vaccine EUA Nausea, vomiting, body aches, fever 100.6
Immediate onset of pain in left deltoid after injection. Deep, aching pain unrelieved with Tylenol or Advil. Aches all the time. Wakes me up at night if I rolled onto it. 6 ultrasound treatment by chiropractor did not relieve the pain. Saw local physician for evaluation 8/3 with MRI scheduled 9/9.
COVID ARM. RED RASH ON ARM WITH SHOT    RASH IS RAISE AND ABOUT 1-2 inches
Chills; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) in a 96-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042120A and 025A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CHILLS (Chills). At the time of the report, CHILLS (Chills) had not resolved.            No concomitant medication details was reported. No treatment medication details was reported.
Patient received  first COVID vaccine  on 1/13/2021 (left deltoid). Scheduled for second 2/2/2021. - Rash began 1/18/2021 right upper back. Large patch of erythematous based small vesicular papules on right upper back just above bra line. Does not extend past spinal cord. Right lateral breast 3 small patches of less red fine papules.
Patient states that he started experiencing small bumps that were painful across both shoulders within 72 hours of receiving the vaccine. The bumps were not a visible rash but could be felt by the patient and was very painful. The reaction has improved daily per the patient
Got a huge baseball size hard red hot spot on her arm. Was very sore. No fever. Lasted started Thursday night, worse Friday and over the weekend. Lasted approximately 5 days, warm compresses.
Headache, Myalgia, Fever, UrticariaPruritus, Fatigue
pt was given flu vax 1OCT93 & w/in 1 wk devel sx of GBS w/resp failure requiring ventilator support & 3 heart blocks requiring pacemaker; pt devel complication of pneumonia later on ventilator & died secondary to sepsis w/in wks;
Eight days after shot I?m getting a rash and itching and swelling at the sight. It?s hot to the touch as well.
Fever and cold; Injection Site Pain; Allergic Reactions; Fever and cold; This is a spontaneous report from a contactable consumer (patient, self-reporting). A 19-year-old male patient received unspecified dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Lot Number: EN6198 and Expiry date was not reported), via an unspecified route of administration on 01Mar2021 (age at vaccination was 19-year-old) as dose number unknown, single for COVID-19 immunisation. The patient medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient concomitant medications were not reported. The patient did not receive other vaccine in four weeks. On 01Mar2021 at 21:00 patient experienced fever and cold, injection site pain (vaccination site pain) and allergic reactions. No treatment received for the events. Outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On an unknown date, the patient might have received an improperly stored dose of either VAQTA 25/0.5 lot# M036459 with expiration date: 18-JAN-2018, lot # M030598 with expiration date 11-AUG-2018, RECOMBIVAX HB lot # M020926 with expiration date 11-AUG-2018, lot # M033334 with expiration date 11-AUG-2018, M-M-R II, lot # M010426 with expiration date 01-MAR-2018, lot # M016233 with expiration date 31-MAR-2018, lot # L041456 with expiration date 22-OCT-2017, GARDASIL 9 lot # M009378 with expiration date 23-APR-2018, lot # L037554 with expiration date 25-DEC-2017 or rotavirus ROTATEQ lot # M004726 with expiration date 19-OCT-2017, lot # reported as M016918 with expiration date reported as 15-FEB-2018). No adverse effects were reported. The vaccines experienced the temperature excursion of 17.7 degrees Celsius for 1 hour 5 minutes. Additional information has been requested.
Reaction at the injection site; arm was swollen; Itchy/occasional itchiness over her whole body; A little bit nausea; A spontaneous report was received from a non healthcare professional concerning a female patient of an unknown age who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced having reaction at the injection site, arm is swollen, itchy/occasional itchiness over her whole body and a little bit of nausea.  Medical history was not reported.  Concomitant medication was not reported.  On 12-Jan-2021, prior to the onset of the events having reaction at the injection site, arm is swollen, itchy/occasional itchiness over her whole body and a little bit of nausea, the patient received their first of two planned doses of mRNA-1273 (lot/batch: 011L20A) via unknown route in unknown anatomical location for prophylaxis of COVID-19 infection.  On 21-Jan-2021, the patient experienced having reaction at the injection site, arm is swollen, itchy/occasional itchiness over her whole body and a little bit of nausea.  Laboratory details was not provided.  Treatment medication was not provided.  Action taken with mRNA-1273 in response to the events having reaction at the injection site, arm is swollen, itchy/occasional itchiness over her whole body and a little bit of nausea was not provided.  The outcome of the events having reaction at the injection site, arm is swollen, itchy/occasional itchiness over her whole body and a little bit of nausea was not reported.  The reporter did not provide the assessment of the events having reaction at the injection site, arm is swollen, itchy/occasional itchiness over her whole body and a little bit of nausea to study drug.
not eaten very much the past few days; feeling weak/not gotten up much; muscle ache from shoulders and down backside; chills; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (muscle ache from shoulders and down backside), CHILLS (chills), ASTHENIA (feeling weak/not gotten up much) and DECREASED APPETITE (not eaten very much the past few days) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     No medical history was provided by the reporter. .     On 15-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced ARTHRALGIA (muscle ache from shoulders and down backside) and CHILLS (chills). On 17-Mar-2021, the patient experienced ASTHENIA (feeling weak/not gotten up much). On an unknown date, the patient experienced DECREASED APPETITE (not eaten very much the past few days). The patient was treated with PARACETAMOL (TYLENOL) for Shoulder pain, at an unspecified dose and frequency. At the time of the report, ARTHRALGIA (muscle ache from shoulders and down backside), CHILLS (chills), ASTHENIA (feeling weak/not gotten up much) and DECREASED APPETITE (not eaten very much the past few days) outcome was unknown. Not Provided          No concomitant medications were provided by the reporter.  The patient did not  eat  very much the past few days and stated that could also be why she felt weak.
This spontaneous report was received from a registered nurse concerning a patient of unknown age and gender. Medical history and concurrent conditions were not reported. On 16-SEP-2014, the patient was vaccinated with a dose of (Oka/Merck) VARIVAX (dose number and route were not reported), 0.5 ml, lot# K005182, expiration date 10-APR-2014 for vaccination. Co-suspect and concomitant therapies were not reported. The registered nurse reported the 26 patients doses of (Oka/Merck) VARIVAX (from lot # K005182, expiration date 10-APR-201 only) that were improperly stored. No adverse effect reported for any of the patients. This is one (1) of twenty seven (27) reports from the same reporter.
Patient stated it started after she took off the band-aid, her arm started to get a little rash. The rash is small with pink bumps barely visible to my eye. The patient said she had been putting alcohol on it.
No adverse event; Patient received a dose of Moderna COVID-19 Vaccine Bivalent on 16Jan2023 instead of the 1st dose of the primary series; This spontaneous case was reported by a physician and describes the occurrence of WRONG PRODUCT ADMINISTERED (Patient received a dose of Moderna COVID-19 Vaccine Bivalent on 16Jan2023 instead of the 1st dose of the primary series) and NO ADVERSE EVENT (No adverse event) in a 43-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7170B) for COVID-19 prophylaxis.     No Medical History information was reported.  On 16-Jan-2023, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 16-Jan-2023,  after starting , the patient experienced WRONG PRODUCT ADMINISTERED (Patient received a dose of Moderna COVID-19 Vaccine Bivalent on 16Jan2023 instead of the 1st dose of the primary series). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Patient received a dose of Moderna COVID-19 Vaccine Bivalent on 16Jan2023 instead of the 1st dose of the primary series) and NO ADVERSE EVENT (No adverse event) outcome was unknown.     For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Patient received a dose of Moderna COVID-19 Vaccine Bivalent on 16Jan2023 instead of the 1st dose of the primary series).    Concomitant product use was not provided by the reporter.  Unknown if patient had receive any other vaccines in the 4 weeks prior to COVID-19 vaccine.  HCP stated they have a report of another facility where a patient received a dose of Moderna COVID-19 Vaccine Bivalent instead of the first dose of the primary series.  Treatment information was not provided.
Patient presented to pharmacy with significant injection site reaction. Pharmacist on duty described it at being a ringlike area about 2x4 inches with a welt in the center like a bee sting.